112452-23-0 Usage
Uses
There are no specific uses mentioned in the provided materials for (3R,4S,5S,6R,7R,9R,11S,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy-10-[(2-methoxyethyl)amino]-. However, its complex structure and the presence of various functional groups suggest that it may have potential applications in the pharmaceutical or chemical industries. Further research and development would be required to determine its specific uses and benefits.
Check Digit Verification of cas no
The CAS Registry Mumber 112452-23-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,2,4,5 and 2 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 112452-23:
(8*1)+(7*1)+(6*2)+(5*4)+(4*5)+(3*2)+(2*2)+(1*3)=80
80 % 10 = 0
So 112452-23-0 is a valid CAS Registry Number.
112452-23-0Relevant academic research and scientific papers
Synthesis and Structure-Activity Relationships of New 9-N-Alkyl Derivatives of 9(S)-Erythromycylamine
Kirst, Herbert A.,Wind, Julie A.,Leeds, James P.,Willard, Kevin E.,Debono, Manuel,et al.
, p. 3086 - 3094 (2007/10/02)
A series of new 9-N-alkyl derivatives of 9(S)-erythromycylamine has been synthesized by reductive alkylation of erythromycylamine with aliphatic aldehydes and sodium cyanoborohydride.Alternative syntheses employing hydrogenation methods have also been dev
